PAB 14.3% 0.6¢ patrys limited

the attractions for amgen

  1. 3,043 Posts.
    lightbulb Created with Sketch. 249
    For those without a memory like a sieve I invite you to post your thoughts on what the drivers were for Amgen to get alongside PAB and their lead product.

    The apparent re-sensitivising (Such a word?) to existing drugs is probably most compelling. I can't remember offhand but was this evident with the Onyx compound or Celenes?

    Have a great day everyone, and apologies if I seem a little negative at times - I understand there's a fair way to go before we see the fruits of the incredible efforts of Patrys to date.

    We haven't heard from Legless in a while but I did enjoy his 'One two' knockout punch interpretation of what Amgen are hoping for in a combo drug. Have a great day everyone.

 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.6¢
Change
-0.001(14.3%)
Mkt cap ! $12.34M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $2.85K 475K

Buyers (Bids)

No. Vol. Price($)
6 2446203 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 3467744 6
View Market Depth
Last trade - 12.07pm 15/08/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.